期刊文献+

根除幽门螺杆菌治疗药物的研究进展 被引量:23

Research Progress of Drug for Eradication of Helicobacter Pylori
暂未订购
导出
摘要 幽门螺杆菌(Hp)不仅与消化性溃疡、胃癌等胃部疾病发生相关,还与冠心病、牙周炎、缺铁性贫血、特发性血小板减少性紫癜、慢性荨麻疹等其他系统疾病的发病相关,Hp感染已成为世界性公共卫生问题。根除Hp利大于弊,因此根除Hp感染成为全球关注的热点。随着抗生素耐药发生率的不断升高,Hp根除治疗药物及方案亦处于不断更新中,但目前首次根除Hp治疗的成功率仍较低。随着治疗方案个体化的进展,对不同国家和地区抗生素耐药机制以及根除Hp药物作用机制、耐药机制和不良反应的研究显得十分重要。 Helicobacter pylori(Hp) is not only related to peptic ulcer,gastric cancer and other gastric diseases,but also to coronary heart disease,periodontitis,iron deficiency anemia,idiopathic thrombocytopenic purpura,chronic urticaria and other systemic diseases.Hp infection has become a worldwide public health problem.Eradicating Hp has more advantages than disadvantages,so it has become a global hotspot.With the increasing of incidence of antibiotic resistance,Hp eradication drugs and programs are also in constant updating,but the first-time success rate of Hp eradication is still low.With the development of individualized treatment,it is very important to study the mechanism of antibiotic resistance,the mechanism of Hp eradication,the mechanism of drug resistance and adverse reactions in different countries and regions.
作者 张俊璇 方超然 时鑫鑫 谭浩雨 郝欣 李建辉 ZHANG Junxuan;FANG Chaoran;SHI Xinxin;TAN Haoyu;HAO Xin;LI Jianhui(Chengde Medical College,Chengde 067000,China;Department of Surgery,Beijing Water Resources Hospital,Beijing 100089,China;Department of Gastroenterology,Chengde Central Hospital,Chengde 067000,China)
出处 《医学综述》 2020年第2期316-321,共6页 Medical Recapitulate
关键词 幽门螺杆菌 根除治疗 质子泵抑制剂 抗生素 铋剂 益生菌 中药 Helicobacter pylori Eradication therapy Proton pump inhibitors Antibiotics Bismuth Probiotics Traditional Chinese medicine
  • 相关文献

参考文献27

二级参考文献270

共引文献1300

同被引文献304

引证文献23

二级引证文献183

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部